Press releases
- Large, Real-world Studies Demonstrate Continued Excellent Outcomes for Patients Receiving Edwards SAPIEN TAVR
- Edwards Lifesciences to Present at the 44th Annual TD Cowen Healthcare Conference
- Edwards Lifesciences Reports Fourth Quarter Results
- Edwards’ EVOQUE Valve Replacement System First Transcatheter Therapy to Earn FDA Approval for Tricuspid Valve
- Edwards Lifesciences to Host Earnings Conference Call on February 6, 2024
- Edwards Lifesciences to Present at the 42nd Annual J.P. Morgan Healthcare Conference
More ▼
Key statistics
Short selling activityProvided by S&P Global Market Intelligence
Open | -- |
---|---|
High | -- |
Low | -- |
Bid | -- |
Offer | -- |
Previous close | -- |
Average volume | -- |
---|---|
Shares outstanding | 601.30m |
Free float | 595.46m |
P/E (TTM) | 41.34 |
Market cap | 57.21bn USD |
EPS (TTM) | 2.30 USD |
--
More ▼